Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
395.50
+4.00 (1.02%)
Aug 19, 2026, 10:19 AM CST

Sunmax Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,0372,0261,8181,6891,4001,036
Revenue Growth
4.74%11.45%7.64%20.64%35.19%21.01%
Gross Profit
1,5931,5891,4791,4051,193894.45
Operating Income
985.11998.31926.96894.8768367.37
Net Income
724.03725.75679.41625.71533.83245.64
Earnings Per Share
13.2713.3112.4611.479.794.51
EPS Growth
-0.44%6.82%8.63%17.16%117.07%3.20%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan Operating Segment
1,1051,049949.18768.19608.38456.86
Mainland China Consolidation Department
1,7861,8081,6651,5341,258929.39
Adjustments and Eliminations
-854.71-830.31-795.73-613.54-465.91-350.59
Total
2,0372,0261,8181,6891,4001,036

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,197961.59865.47961.79816.67679.34
Total Debt
116.04119.33145.21169.0263.0999.18
Net Cash (Debt)
1,081842.26720.26792.78753.58580.16
Net Cash Growth
9.47%16.94%-9.15%5.20%29.89%-25.59%
Net Cash Per Share
19.8315.4413.2114.5413.8210.64

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
821.23825.92561.04848.56644.57243.28
Capital Expenditures
-87.01-59.61-31.97-107.66-154.58-253.02
Free Cash Flow
734.22766.31529.07740.9489.99-9.74
Free Cash Flow Growth
12.97%44.84%-28.59%51.21%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
78.23%78.41%81.33%83.18%85.19%86.37%
Operating Margin
48.37%49.27%50.99%52.98%54.85%35.47%
Pretax Margin
49.39%50.07%52.44%53.84%55.51%34.52%
Profit Margin
35.55%35.82%37.37%37.05%38.13%23.72%
FCF Margin
36.05%37.82%29.10%43.87%35.00%-0.94%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
12.10012.10011.60011.0009.5004.400
Dividend Per Share Growth
0%4.31%5.46%15.79%115.91%120.00%
Dividend Yield
3.14%3.15%4.40%5.93%8.01%6.33%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
29.5029.7222.4517.7613.8818.31
P/FCF Ratio
29.0428.1428.8215.0015.12-
PS Ratio
10.4710.648.396.585.294.34